Search

6 result(s) for 'author#Maureen Lyons-Weiler' within BMC

1. A novel SNP analysis method to detect copy number alterations with an unbiased reference signal directly from tumor samples

   Genomic instability in cancer leads to abnormal genome copy number alterations (CNA) as a mechanism underlying tumorigenesis. Using microarrays and other technologies, tumor CNA are detected by comparing tumor...

   Authors: Alex Lisovich, Uma R Chandran, Maureen A Lyons-Weiler, William A LaFramboise, Ashley R Brown, Regina I Jakacki, Ian F Pollack and Robert W Sobol

   Citation: BMC Medical Genomics 2011 4:14

   Content type: Software Published on: 26 January 2011

   • View Full Text
   • View PDF

2. Virtual karyotyping with SNP microarrays reduces uncertainty in the diagnosis of renal epithelial tumors

   Renal epithelial tumors are morphologically, biologically, and clinically heterogeneous. Different morphologic subtypes require specific management due to markedly different prognosis and response to therapy. ...

   Authors: Jill M Hagenkord, Anil V Parwani, Maureen A Lyons-Weiler, Karla Alvarez, Robert Amato, Zoran Gatalica, Jose M Gonzalez-Berjon, Leif Peterson, Rajiv Dhir and Federico A Monzon

   Citation: Diagnostic Pathology 2008 3:44

   Content type: Research Published on: 6 November 2008

   • View Full Text
   • View PDF

3. The colonization of land by animals: molecular phylogeny and divergence times among arthropods

   The earliest fossil evidence of terrestrial animal activity is from the Ordovician, ~450 million years ago (Ma). However, there are earlier animal fossils, and most molecular clocks suggest a deep origin of an...

   Authors: Davide Pisani, Laura L Poling, Maureen Lyons-Weiler and S Blair Hedges

   Citation: BMC Biology 2004 2:1

   Content type: Research article Published on: 19 January 2004

   • View Full Text
   • View PDF

4. Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression test

   Carcinomas of unknown primary (CUP) represent approximately 3%-5% of malignant neoplasms. Identifying the tissue of origin (TOO) in these tumors allows for more specific treatment and improves outcomes. Howeve...

   Authors: Federico A Monzon, Fabiola Medeiros, Maureen Lyons-Weiler and W David Henner

   Citation: Diagnostic Pathology 2010 5:3

   Content type: Research Published on: 13 January 2010

   • View Full Text
   • View PDF

5. Serum protein profiles predict coronary artery disease in symptomatic patients referred for coronary angiography

   More than a million diagnostic cardiac catheterizations are performed annually in the US for evaluation of coronary artery anatomy and the presence of atherosclerosis. Nearly half of these patients have no sig...

   Authors: William A LaFramboise, Rajiv Dhir, Lori A Kelly, Patricia Petrosko, John M Krill-Burger, Christin M Sciulli, Maureen A Lyons-Weiler, Uma R Chandran, Aleksey Lomakin, Robert V Masterson, Oscar C Marroquin, Suresh R Mulukutla and Dennis M McNamara

   Citation: BMC Medicine 2012 10:157

   Content type: Research article Published on: 5 December 2012

   • View Full Text
   • View PDF

6. Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process

   Prostate cancer is characterized by heterogeneity in the clinical course that often does not correlate with morphologic features of the tumor. Metastasis reflects the most adverse outcome of prostate cancer, a...

   Authors: Uma R Chandran, Changqing Ma, Rajiv Dhir, Michelle Bisceglia, Maureen Lyons-Weiler, Wenjing Liang, George Michalopoulos, Michael Becich and Federico A Monzon

   Citation: BMC Cancer 2007 7:64

   Content type: Research article Published on: 12 April 2007

   • View Full Text
   • View PDF